Eczema (atopic dermatitis) is a chronic inflammatory skin condition causing intensely itchy, dry, inflamed skin that can significantly impair quality of life and sleep. It affects approximately 31 million Americans of all ages and often coexists with other allergic conditions — asthma and allergic rhinitis — as part of the “atopic triad.” Medical clinics — particularly dermatology and allergy practices — provide the comprehensive management that keeps eczema under control. This guide explains clinical care for eczema and skin allergies.
Understanding Eczema
Eczema involves a defect in the skin barrier that allows irritants and allergens to penetrate the skin and trigger immune activation. The resulting inflammation produces the characteristic itching, redness, scaling, and sometimes oozing that define eczema flares. Trigger factors — certain soaps, detergents, fabrics, environmental allergens, stress, sweat, and certain foods — vary between individuals. Identifying and avoiding personal triggers, combined with appropriate medical treatment, forms the basis of eczema management.
Treatment Approaches
Moisturization
Consistent, generous moisturizer application is the cornerstone of eczema management — maintaining skin barrier function, reducing water loss, and decreasing flare frequency. Thick creams and ointments (petroleum jelly, CeraVe, Eucerin) are more effective than lotions. Apply immediately after bathing on still-damp skin.
Topical Medications
Topical corticosteroids are the first-line treatment for eczema flares — applied to inflamed areas for limited periods to reduce inflammation. Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid-free alternatives suitable for sensitive areas. Topical PDE4 inhibitor (crisaborole) provides another non-steroidal option.
Biologics for Severe Eczema
Dupilumab (Dupixent), a biologic injection targeting the IL-4/IL-13 inflammatory pathway, produces dramatic improvement in patients with moderate to severe eczema who have not responded adequately to topical treatments. Newer biologics (tralokinumab, lebrikizumab) provide additional options.
Conclusion
Eczema does not have to dominate your life. Consistent skin care, trigger avoidance, and appropriate medical treatment — escalated to biologic therapy for severe cases — can bring eczema under meaningful control. If your current treatment is not providing adequate relief, discuss with your dermatologist or allergist — the range of available treatments has expanded remarkably in recent years.
FAQs – Eczema
Q1. Does eczema ever go away?
A: Many children see significant improvement or apparent resolution of eczema by adulthood. However, the underlying skin barrier dysfunction persists, and eczema may return during adulthood — particularly during periods of stress, hormonal change, or increased environmental exposure.
Q2. Can food allergies cause eczema?
A: In young children, certain food allergies (dairy, egg, peanut, wheat) can trigger or worsen eczema. Elimination diets should only be pursued under medical supervision, as unnecessary food elimination can impair children’s nutrition and may not help eczema if food allergy is not the true driver.
Q3. Are steroids safe to use on skin long-term?
A: High-potency topical steroids used long-term can cause skin thinning. Low-to-moderate potency steroids used as directed for limited periods are safe. For areas requiring ongoing treatment (face, skin folds), non-steroidal topical options are preferred. Follow your dermatologist’s guidance on appropriate steroid strength and duration.
Q4. Is eczema contagious?
A: No. Eczema is not infectious and cannot be transmitted by touching affected skin. However, eczema can become infected — superimposed bacterial, viral, or fungal infections are a common complication requiring specific treatment.
Q5. Can stress cause eczema to flare?
A: Yes. Stress activates inflammatory pathways that worsen eczema. Stress management strategies (relaxation techniques, adequate sleep, psychosocial support) complement dermatological treatment by addressing a significant trigger factor.
